An in-depth look to INFANT BACTERIAL THERAPEUTICS AB SER. B operating, investing, and financing activities

IBT_B free cash flow for Q3 24 is -42.25 M SEK. For 2023, IBT_B free cash flow was -101.22 M SEK and operating cash flow was -101.22 M SEK.